Startpagina Podcasts Inside EMA
Inside EMA

Inside EMA

European Medicines Agency 8 afleveringen okt. 20, 2026

The official podcast of the European Medicines Agency. This series takes you behind the scenes of medicines regulation in the EU, exploring the science and the experts working to ensure medicines for humans and animals are safe, effective, and of high quality.

Afleveringen

What’s the buzz about bees?
What’s the buzz about bees? okt. 20, 2026 21:05 Bees are essential to our ecosystems, food production and biodiversity. But like all animals, they can face health challenges. In the latest episode of Inside EMA, we speak with Miguel Llorens, Scientific Officer in EMA's Veterinary Medicines Division, about the diseases affecting bees, the medicines used to treat them, and how regulators help ensure those medicines are safe, effective and of
Inside EMA: The traineeship experience.
Inside EMA: The traineeship experience. sep. 3, 2026 25:58 What is it really like to be an EMA trainee?In the latest episode of Inside EMA, we speak with Maria Iglesias, Martin Botulinski and Andrea Tzoneva about their experiences of EMA's traineeship programme. From regulatory science and innovation to institutional policy, they discuss learning opportunities, mentorship, international collaboration and the diverse career paths that can lead to EMA.
Better science, better medicines: how innovation is reshaping animal testing
Better science, better medicines: how innovation is reshaping animal testing jul. 27, 2026 23:29 Could medicines one day be developed without animal testing? Scientific innovation is advancing rapidly, and momentum is growing in Europe and globally to reduce andultimately replace the use of animals in research. The EU has launched a roadmap towards phasing out animal testing for chemical safety assessments, and EMA continues to build on its longstanding commitment to the 3Rs principles  (repl
Evidence for two: medicines in pregnancy and breastfeeding
Evidence for two: medicines in pregnancy and breastfeeding jun. 23, 2026 19:05 Up to 90% of women who are pregnant or breastfeeding use medicines, yet for many of these treatments, reliable safety data remains limited. Why does this gap exist—and how can it be addressed?In this episode of Inside EMA, Corinne de Vries, EMA lead on medicines in pregnancy and breastfeeding, explores the challenges of generating robust safety evidence for these populations. She explains how trad
Data, trust and the future of medicines
Data, trust and the future of medicines mei 28, 2026 28:40 From clinical trials to real‑world evidence. How is data shaping the future of medicines?Discover how EMA uses data to guide safer, better decisions.  In this episode of Inside EMA, we explore how different types of data are shaping the future of medicines regulation in Europe. EMA experts Peter Arlett and Denise Umuhire explain how real-world evidence - data from electronic healthcare records - c
From idea to medicines: how EMA supports innovation
From idea to medicines: how EMA supports innovation apr. 23, 2026 22:32 How does EMA help turn innovative ideas into real medicines?In this episode of Inside EMA, we look at how the European Medicines Agency supports developers from early concepts through to patient access. The discussion highlights how regulation and innovation are not opposites, but complementary forces that help deliver safe and effective medicines.Topics include early scientific dialogue, support
Beyond the scale, obesity in the age of GLP-1s
Beyond the scale, obesity in the age of GLP-1s mrt. 30, 2026 24:59 Obesity rates continue to rise across Europe, but the reasons go far beyond diet and exercise. In this episode, we explore obesity as a chronic disease and look at how weight‑loss medicines like GLP‑1 receptor agonists are influencing treatment and expectations. EMA expert Bart van der Schueren joins us to discuss the biological, behavioural and societal factors that influence weight, and what it
Inoculated with doubt: misinformation and public trust
Inoculated with doubt: misinformation and public trust feb. 18, 2026 26:46 This episode of ‘Inside EMA’ delves into one of today’s most pressing public health challenges: health misinformation. Konstantina Boumaki, from the European Patients’ Forum EPF), and Steffen Thirstrup, EMA’s Chief Medical Officer, address the rise of health misinformation, the drivers of trust, especially among young people, and the actions EMA is taking to strengthen confidence in medicines and
Shortages of medicines: a balancing act
Shortages of medicines: a balancing act jan. 22, 2026 34:16 Medicine shortages are a growing challenge in today’s complex global supply chain. In this episode of Inside EMA, Monica Dias, EMA’s Head of Supply and Availability of Medicines and Medical Devices, joins communications officers Alessandro Faia and Giulia Gabrielli to explain how the Agency works, together with national authorities, to prevent and manage shortages across the EU.They also discuss t
The next pandemic: are we ready?
The next pandemic: are we ready? dec. 15, 2025 20:29 When it comes to the next pandemic, the question is likely not to be about if it might happen, but rather when. In this episode, Marco Cavaleri, EMA’s Head of Public Health Threats, discusses with communications officer Sophie Labbe the Agency’s and his personal experience of the COVID-19 pandemic, the reasons why new pandemics are likely to occur, and how EMA is preparing for it.
The drugs don’t work: Addressing antimicrobial resistance
The drugs don’t work: Addressing antimicrobial resistance nov. 18, 2025 22:37 To mark European Antibiotic Awareness Day, our first episode dives into one of the biggest global health challenges: antimicrobial resistance (AMR). EMA’s Chief Medical Officer, Steffen Thirstrup, and Communications Officer, Alessandro Faia, explore what drives AMR, its impact in Europe and worldwide, and how EMA is working to enable solutions.Discover why “the drugs don’t work” and what’s being d

Aanbevolen